Gainers
- FibroBiologics, Inc. - Common Stock FBLG shares increased by 25.0% to $17.43 during Tuesday's after-market session.
- Sonnet BioTherapeutics SONN stock moved upwards by 13.46% to $1.77. The company's market cap stands at $5.4 million.
- GlucoTrack GCTK stock rose 12.19% to $0.23. The company's market cap stands at $4.8 million.
- Clene CLNN shares moved upwards by 9.92% to $0.47. The market value of their outstanding shares is at $59.7 million.
- Larimar Therapeutics LRMR shares moved upwards by 8.69% to $9.5. The company's market cap stands at $417.1 million.
- BiomX PHGE shares rose 6.83% to $0.24. The company's market cap stands at $10.8 million.
Losers
- QuidelOrtho QDEL stock declined by 28.2% to $47.9 during Tuesday's after-market session. The company's market cap stands at $3.2 billion. As per the press release, Q4 earnings came out today.
- Alzamend Neuro ALZN stock declined by 12.74% to $0.8. The market value of their outstanding shares is at $5.2 million.
- Assure Hldgs IONM shares decreased by 9.84% to $0.27. The market value of their outstanding shares is at $1.8 million.
- Adial Pharmaceuticals ADIL stock decreased by 8.48% to $1.08. The market value of their outstanding shares is at $1.7 million.
- NeuroOne Medical Tech NMTC stock decreased by 7.81% to $1.3. The market value of their outstanding shares is at $33.6 million. As per the press release, Q1 earnings came out today.
- NanoString Technologies NSTG stock fell 7.09% to $0.1. The company's market cap stands at $4.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ALZNAlzamend Neuro Inc
$1.10-12.0%
CLNNClene Inc
$4.402.33%
FBLGFibroBiologics Inc
$2.2510.8%
GCTKGlucoTrack Inc
$0.269821.7%
IONMAssure Holdings Corp
$0.05120.20%
LRMRLarimar Therapeutics Inc
$4.092.76%
NMTCNeuroOne Medical Technologies Corp
$0.75820.03%
PHGEBiomX Inc
$0.5523-3.00%
QDELQuidelOrtho Corp
$44.844.21%
SONNSonnet BioTherapeutics Holdings Inc
$1.57-1.24%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in